As the population ages, cancers will become more common, even though at the same time cancer treatments are evolving. New drug therapies are being developed and efforts are being made to make the old treatments more effective. Cancer treatments are not well-tolerated and have a wide-ranging impact on the quality of life. It is therefore important to develop methods to improve patients’ quality of life during and after cancer treatments.
I am currently investigating prostate cancer as a postdoctoral researcher at the University of Tampere. In our research group, we conduct not only translational basic research related to the cancer microenvironment and lipid metabolism, but also clinical drug trials and clinical trials aimed at improving the quality of life of patients. In addition, we utilize Finnish registry data in our pharmacoepidemiological research.